Posts by Sandra Ansanay-Alex
Seprify SA & Xemperia, finalists of the IFF Prize
The State of Fribourg and BCF announce the nine finalists for the IFF Prize. 9 companies, out of 39 applications, have been selected. Two of them, Xemperia and Seprify, are promising start-ups of the Swiss Health Valley. Seprify SA: A white pigment derived from cellulose Seprify develops and produces plant-based ingredients to offer…
Read MoreFDA Clears Abionic’s IVD CAPSULE PSP for Early Detection of Sepsis
Abionic, a Vaud-based medical diagnostics company, announced that its IVD CAPSULE PSP test received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This test, designed for the early detection of sepsis, represents a major breakthrough in sepsis diagnostics by significantly reducing the time-to-detection, potentially improving patient outcomes. The FDA clearance marks an important…
Read MoreThe CHUV launches the Swiss BioMotion Lab
This laboratory, which specialises in the analysis and rehabilitation of movement, will enable large-scale research to be carried out and patients, particularly those suffering from osteoarthritis, to benefit from biomechanical data that until now has been used mainly in research. Osteoarthritis is the most common joint disease, marked by the progressive breakdown of…
Read MorePerivision raises CHF 1.1 Million
PeriVision, Inselspital and the University of Bern receive a CHF 1.1 Million grant to build new functional eye tests in retinal diseases like age-related macular degeneration (AMD), geographic atrophy (GA) or diabetic retinopathy (DR) which affect hundreds of millions worldwide. Normally, patients with AMD, GA or DR struggle with standard eye tests such as…
Read MoreA breakthrough in the fight against brain cancer
Researchers at HUG and UNIGE have succeeded in generating cells that kill diseased cells. It works on mouse glioblastoma. Glioblastoma is the most common and most aggressive brain tumour. Current treatments are not very effective: average survival after diagnosis is less than two years. But science is making progress. A team from the University…
Read MoreIntuitive Expands in the Canton of Vaud
Intuitive, a pioneer of robotic-assisted surgery, has expanded its European headquarters in Aubonne, now employing over 250 people. Founded in 1995 in California (USA), Intuitive is the manufacturer of the da Vinci surgical system, a minimally invasive robotic-assisted surgical platform, which has been used by skilled surgeons worldwide for more than two decades.…
Read MoreGenolier Innovation Hub – A Pioneer in Medical Innovation
The Genolier Innovation Hub was inaugurated this Friday 27 September in canton of Vaud. With a CHF 100 million investment, the site aims at fostering innovation in healthcare in the Swiss Health Valley and internationally. Positioned next to the Genolier clinic, the 25,000 square-meter building is designed to encourage interdisciplinary collaboration between research, industry,…
Read Moreten23 health Opens State-of-the-Art VIVA2® Sterile Manufacturing Facility in Visp
This advanced, energy-efficient plant will enhance the company’s capabilities in commercial and clinical manufacturing of sterile medicines, including vials, syringes, and cartridges. The Swiss CDMO celebrates the grand opening of its VIVA2® facility in Visp. The facility adds two production lines: Line 2, designed for large-scale filling of ready-to-use containers, and Line 3,…
Read MoreAlithea Genomics Secures Loan from Swiss Technology Fund
Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics based in canton of Vaud, has received significant support from Switzerland’s Technology Fund in the form of a loan guarantee. The Technology Fund of the Swiss Federal Office for the Environment FOEN uses loan guarantees to support companies developing…
Read MoreNeo Medical completes a $68 million Series B financing round
Neo Medical SA (Neo), a Lausanne-Based technology company specialising in spine surgery, has announced the successful completion of its Series B financing round, including the conversion of existing shareholder loans. With this financing round, Neo has secured an additional equity investment of up to $68 million (CHF 58 million) to accelerate its global growth. …
Read More